Since the last decade, technologies and techniques for rapid sequencing of human genomes have made incredible strides.
Since the last decade, technologies and techniques for rapid sequencing of human genomes have made incredible strides. The advent of high-throughput sequencing technologies—sensors and tools—has opened up a vast area of research in human biology, human diseases, and treatment responses in animals. In particular, stakeholders in the DNA sequencing market with the help of newly-commercialized technologies have been able to unearth vast amount of information on genetic and genomic factors underlying diseases.
Over the years, exome sequencing and whole genome sequencing have established their role in clinical applications in population studies. A case in point is the diagnostic application of DNA sequencing in oncology research. Further, advances in DNA sequencing market have helped paved way to understanding the pathogenetic mechanisms of complex diseases such as neurodegenerative diseases. Also, strides in the DNA sequencing market is one of the key accelerators of research of numerous rare diseases.
Get Brochure of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=6845
DNA Sequencing Market: Key Trends
The emergence of new technologies has considerably reduced the cost of new generation sequencing (NGS), opening new vistas in biochemistry and molecular genetics. One of the key trends opening new application area in the DNA sequencing market is the growing use of sensors, increasingly assisted by incredible strides made in nanotechnology and computing. The adoption of NGS has led to massive parallelization of the sequencing process, enabling researchers to read millions of sequences simultaneously.
The DNA sequencing market has witnessed a rapid growth momentum on the back of the adoption of next generation sequencing platforms. Over the years, chip-based genotyping approaches have become increasingly attracted and have been combined with some of the first few generations of sequencing technologies. Further, the market has seen new application areas due to the adoption of NSG for studying cancer genomes in all their variation. In recent years, researchers have shown vast interest in harnessing the potential of third generation of DNA sequencing in diagnosis and therapeutics of cancer. For instance, the use of these technologies for detecting pharmogenetic variants has gathered steam among industry players. The advent of microarray platforms is also a promising development in the DNA sequencing market.
DNA Sequencing Market: Competitive Dynamics
In recent years, industry players and academia have been leaning on leveraging the potential of DNA sequencing platforms in massive human genome studies. Aspiring players are also keen on overcoming the challenges of understand DNA sequence variants related to human diseases. Some industry players are also increasing their bets on single molecule real-time sequencing (SMRT) in a bid to adopt the recent array of DNA sequencing methodologies. A case in point is Pac Bio sequencing.
Some of the lifesciences companies are trying to unlock new potential of NSG in cardiovascular diseases, apart from cancer, in order to gain a competitive edge over others in the DNA sequencing market. Some of the players have recently started breaking the norm. They are providing sequencing service that exceeds the expectation of end users. A case in point is Complete Genomics, Inc. Some of the top players are also eyeing opportunities in the analysis of high-throughput sequence data.
Get Table of Content of the Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=6845
DNA Sequencing Market: Regional Assessment
The DNA sequencing market has seen vast strides in North America and Europe. A growing body of ambitious projects pertaining to NGS is a key trend broadening the canvas for stakeholders in the market. Further, numerous countries in the region have seen players forking out dollars in human genome project aimed toward studying human diseases, particularly cancer and rare diseases. The vast appetite for a wide variety of next generation sequencing technologies has unlocked new potential in countries such as the U.S. Players in these regional market are also keen on adopting new approaches, increasing the role of these markets in the global landscape.
5-Point Growth Formula
The 5-point growth formula developed by TMR Research provides an insight to the stakeholders and CXOs about the current situation in the market. The growth formula makes the report a perfect companion for the stakeholders and CXOs.
The 5-point growth formula includes the following points:
- Current and Future Threats
- Accurate Trend Analysis
- Regional Assessment
- Industrial Analogy
- COVID-19 Impact
Get Discount on the Latest Report @ https://www.tmrresearch.com/sample/sample?flag=D&rep_id=6845
The reports offer answers to the top 7 questions that revolve around the growth of the market
- What are the diverse growth parameters influencing the market?
- Which regions will contribute largely to the growth of the market
- What are the recent innovations and technological advancements in the market?
- What are the emerging trends across the market?
- How has COVID-19 affected the market?
- What will be the post-pandemic scenario of the market?
- What are the major threats that will dent the growth prospects of the market?
About TMR Research
TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.
Contact:
Rohit Bhisey
TMR Research,
3739 Balboa St # 1097,
San Francisco, CA 94121
United States
Tel: +1-415-520-1050
Visit Site: https://www.tmrresearch.com/